Tolosa, Eduardo.
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Eduardo Tolosa
Tolosa, Eduardo Tolosa Sarró
Tolosa, E.
Tolosa Sarró, Eduardo
VIAF ID: 61647937 (Personal)
Permalink: http://viaf.org/viaf/61647937
Preferred Forms
-
100 0 _
‡a
Eduardo Tolosa
-
100 1 _ ‡a Tolosa Sarró, Eduardo
-
200 _ |
‡a
Tolosa
‡b
Eduardo
-
100 1 _ ‡a Tolosa, E.
-
100 1 _ ‡a Tolosa, Eduardo
-
100 1 _ ‡a Tolosa, Eduardo
-
100 1 _ ‡a Tolosa, Eduardo
-
100 1 _ ‡a Tolosa, Eduardo
-
100 1 _
‡a
Tolosa, Eduardo
-
100 1 _
‡a
Tolosa, Eduardo
-
100 1 _
‡a
Tolosa, Eduardo
-
100 1 _ ‡a Tolosa, Eduardo
-
100 1 _ ‡a Tolosa, Eduardo
-
100 1 _
‡a
Tolosa, Eduardo
-
100 1 _
‡a
Tolosa, Eduardo
‡q
Tolosa Sarró
-
100 1 _ ‡a Tolosa, Eduardo.
4xx's: Alternate Name Forms (13)
Works
| Title | Sources |
|---|---|
| Alteraciones funcionales de circuitos reflejos del tronco cerebral en pacientes parkinsonianos |
|
| Angiografía cerebral |
|
| Anticossos antigangliosids en l'esclerosi múltiple |
|
| Aplicaciones clínicas de la implantación crónica de electrodos subdurales |
|
| Autobiografía de la Sociedad Española de Neurología (1949-1994) y otras memorias de la neurología española |
|
| Brainstem reflexes and functions |
|
| Cómo mantener la calidad de vida en pacientes con Parkinson |
|
| Control motor normal y patológico |
|
| Curso de migrañas y otras cefaleas primarias |
|
| Demencia senil : nuevas perspectivas y tendencias terapéuticas |
|
| Dopamine levodopa-induced dyskinesias fluctuations in Parkinson's disease |
|
| Efectes de la toxina botulímica en la neurofisiologia del torticoli espasmòdic : implicacions fisiopatològiques |
|
| Enfermedad de Alzheimer |
|
| Espectro de enfermedades neurológicas asociadas a anticuerpos anti-glutamato decarboxilasa (GAD) |
|
| Estudi morfológic, morfomètric i immunocitoquímic de les motoneurones espinals en l'envelliment fisiològic. Anàlisi comparativa amb l'esclerosi lateral amiotròfica |
|
| Estudio de la perfusión cerebral regional mediante SPECT con 99m Tc-HMPAO, patrón de normalidad y estudios de neouroactivación |
|
| Estudio del funcionalismo dopaminérgico en el cerebro de rata tras la administración de fármacos antagonistas de canales de calcio |
|
| Facial dyskinesias, c1988: |
|
| Factors genètics i d'expressió implicats en la patogènia de la malaltia de Parkinson idiopàtica i associada a la mutació G2019S a LRRK2 |
|
| How to run a brain bank, c1993: |
|
| Implicación de los genes MAPT y PGRN en la degeneración lobar frontotemporal: mecanismos patgénicos y expresión fenotípica |
|
| Inflammatory profile in LRRK2-associated prodromal and clinical PD |
|
| Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials |
|
| Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population |
|
| Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients |
|
| Late-stage Parkinson's disease: the Barcelona and Lisbon cohort |
|
| LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. |
|
| LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance |
|
| Malaltia de Gilles de la Tourette: estudi del reflexe orbicularis oculi amb estimuls elèctrics |
|
| Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial |
|
| Movement disorders: advances on many fronts |
|
| Mutational study of the nuclear factor kappa B inducing kinase gene in patients with progressive supranuclear palsy |
|
| The natural history of multiple system atrophy: a prospective European cohort study |
|
| Neurodegenerative disorders associated with [alfa]-synuclein pathology |
|
| Neuropsychological deficits in Parkinson's disease patients with visual hallucinations |
|
| Nocturnal paroxysmal dystonia related to a prerolandic dysplasia |
|
| Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease |
|
| A novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndrome |
|
| A Novel p.Glu298Lys Mutation in the ACMSD Gene in Sporadic Parkinson's Disease |
|
| Paediatric movement disorders progress in understanding |
|
| Parkinson : Qué ens cal saber |
|
| Parkinsonismo experimental y humano : efectos y mecanismos de acción de las aporfinas |
|
| Parkinson's disease and movement disorders |
|
| The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases |
|
| Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry |
|
| Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study |
|
| Prevalencia, fenotipo clínico y neuropatológico del parkinsonismo asociado a mutaciones en el gen LRRK2 |
|
| The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies |
|
| Progressive supranuclear palsy : diagnosis, pathology, and therapy |
|
| Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome |
|
| Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease |
|
| Safety analysis of 10 clinical trials and for 13 years after first approval of ioflupane 123I injection (DaTscan). |
|
| Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study |
|
| Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration |
|
| Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study |
|
| Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study |
|
| Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). |
|
| Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial |
|
| Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA. |
|
| Transient arrest of psychogenic tremor induced by contralateral ballistic movements |
|
| Tratado sobre la enfermedad de Parkinson |
|
| UCHL-1 gene in multiple system atrophy: a haplotype tagging approach |
|
| Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study |
|
| Usefulness of the SINBAR electromyographic montage to detect the motor and vocal manifestations occurring in REM sleep behavior disorder |
|
| Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
|
| Wyzwania w diagnostyce choroby Parkinsona = Challenges in the diagnosis of Parkinson's disease |
|
| α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain |
|
